Obesity is associated with altered thermoregulatory responses, predisposing individuals to greater risk of heat-related morbidity and mortality. This review synthesizes current evidence on the impact of obesity on heat-response profiles, elucidating underlying mechanisms and clinical implications. Integrating recent PubMed-indexed studies, we discuss epidemiological trends, pathophysiological adaptations, risk factors, clinical features, diagnostic strategies, and management approaches, with an emphasis on guideline-based and emerging personalized interventions. The article aims to provide clinicians with an updated, mechanistic understanding to inform risk stratification, preventive care, and individualized management of heat-susceptible obese populations.
The global epidemic of obesity presents multifaceted challenges for healthcare, including an increased vulnerability to environmental stressors such as heat. With rising ambient temperatures and more frequent heatwaves due to climate change, understanding the interplay between obesity and heat-response has become a critical clinical priority. Obese individuals exhibit distinct physiological and molecular responses to heat exposure, which can compromise their ability to dissipate excess body heat, leading to higher rates of heat-related illnesses. This review delineates the personalized heat-response profiles in obesity, offering an integrated perspective for clinicians managing at-risk patients.
Obesity, defined by a body mass index (BMI) ≥30 kg/m², affects over 650 million adults globally, with a rising prevalence in both developed and developing nations. The intersection of obesity and heat-related illness is particularly concerning during heatwaves, when hospitalizations and mortality sharply increase among obese populations. Epidemiological studies, including longitudinal analyses from the United States, Europe, and Asia, consistently report that obesity independently raises the risk of heat exhaustion, heat stroke, and cardiovascular complications during heat exposure. Notably, excess morbidity is not limited to older adults; children and young adults with obesity also demonstrate heightened heat sensitivity. These findings underscore the importance of tailored preventive strategies in clinical practice.
The pathophysiological basis for altered heat-response in obesity is multifactorial. Adipose tissue acts as an insulator, impeding heat dissipation via conduction and convection. Moreover, increased subcutaneous fat alters skin blood flow and reduces evaporative cooling efficiency. At the cellular level, obese individuals exhibit impaired sweating responses due to dysregulated sympathetic nervous system activity and altered expression of sweat gland ion channels. Mitochondrial dysfunction, chronic low-grade inflammation, and oxidative stress further compromise thermoregulatory mechanisms. Endocrine alterations, including leptin resistance and insulin dysregulation, modulate hypothalamic control of temperature homeostasis. Recent studies highlight the role of adipokines and pro-inflammatory cytokines in blunting cutaneous vasodilation, thereby increasing core body temperature during heat stress.
Several risk factors modulate the severity of heat-response impairment in obese individuals. These include higher degrees of adiposity, central (visceral) fat distribution, physical inactivity, comorbidities such as cardiovascular disease, diabetes, and obstructive sleep apnea, as well as certain medications (e.g., anticholinergics, diuretics). Age, sex, genetic polymorphisms affecting thermoregulatory pathways, and socioeconomic factors influencing access to cooling resources also contribute to personalized risk profiles. Understanding these variables enables targeted intervention and risk reduction.
Obese patients exposed to heat may present with a spectrum of clinical manifestations, ranging from mild heat intolerance to severe heat stroke. Early symptoms include excessive fatigue, nausea, dizziness, and profuse or paradoxically reduced sweating. Progression to heat exhaustion is marked by tachycardia, hypotension, confusion, and syncope. In severe cases, heat stroke ensues, characterized by altered mental status, core body temperature above 40°C, multiorgan dysfunction, and potential fatality. Notably, obese individuals may exhibit atypical presentations, such as subtle neurological symptoms or delayed recognition of heat-related distress. Vigilance and high clinical suspicion are warranted during periods of elevated environmental temperatures.
Diagnosis of heat-related illness in obesity relies on a thorough clinical assessment, careful history-taking, and physical examination. Core temperature measurement (rectal or esophageal) is essential for accurate diagnosis, as peripheral measurements may be unreliable in obese patients. Laboratory investigations should assess for rhabdomyolysis, electrolyte disturbances, acute kidney injury, and hepatic dysfunction. Ancillary tools, such as continuous temperature monitoring and wearable biosensors, are emerging to enhance early detection in high-risk populations. Risk stratification algorithms, integrating BMI, comorbidities, medication use, and environmental exposure, aid in identifying patients requiring heightened surveillance.
Immediate management of heat-related illness in obese individuals centers on rapid cooling, hemodynamic stabilization, and organ support. External cooling modalities, including evaporative and conductive techniques, are effective but may be technically challenging due to body habitus. Intravenous fluid resuscitation, electrolyte correction, and monitoring for complications are critical components. Preventive strategies encompass patient education regarding heat avoidance, hydration, acclimatization protocols, and modification of physical activity during peak heat periods. Pharmacological considerations include reviewing medications that impair thermoregulation and optimizing treatment of comorbidities. Multidisciplinary care involving primary care, endocrinology, cardiology, and physical therapy enhances outcomes.
Recent advances focus on precision medicine approaches to personalize heat-response mitigation in obesity. Wearable physiological monitors provide real-time assessment of core temperature, sweat rate, and hemodynamic status, enabling individualized preventive interventions. Pharmacological agents targeting adipokine signaling, mitochondrial function, and cutaneous vasodilation are under investigation. Behavioral interventions, including digital health platforms and telemedicine, facilitate patient engagement and remote risk monitoring. Ongoing research aims to elucidate genetic determinants of thermoregulatory capacity and develop targeted therapies to enhance heat tolerance in obese populations.
Current clinical guidelines from organizations such as the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) emphasize risk assessment, patient education, and environmental precautions for obese individuals during heatwaves. Key recommendations include proactive identification of high-risk patients, structured heat safety counseling, periodic medication review, and adaptation of exercise regimens. Clinical practice should incorporate multidisciplinary collaboration and leverage emerging technologies for early detection and intervention. Continued research is needed to refine risk stratification tools and optimize personalized management protocols.
Obesity significantly modifies heat-response profiles, increasing susceptibility to heat-related morbidity and mortality. A mechanistic understanding of impaired thermoregulation, combined with individualized risk assessment and evidence-based management, is essential for optimizing outcomes in this vulnerable population. Advances in personalized monitoring and emerging therapies hold promise for improving heat resilience among obese patients. Clinicians must remain vigilant and proactive, integrating evolving evidence and guidelines into routine care to mitigate the impact of rising environmental temperatures on obese individuals.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation